OrthoSensor
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$3.4m | Series A | ||
$1.6m | Series A | ||
$1.0m | Series A | ||
$3.0m | Convertible | ||
$21.0m | Series B | ||
$15.0m | Series B | ||
N/A | $13.0m | Series B | |
$19.0m | Series C | ||
N/A | $970k | Seed | |
N/A | $21.4m | Debt | |
$52.0m | Acquisition | ||
Total Funding | $78.0m |
Related Content
Recent News about OrthoSensor
EditOrthoSensor, Inc. is a company that specializes in quantifying orthopaedics through the use of sensor-assisted technology. The business operates in the healthcare sector, specifically focusing on musculoskeletal care. OrthoSensor's products are designed to enable healthcare providers to deliver evidence-based treatments, which are treatments supported by data and research, thereby improving both clinical outcomes for patients and economic outcomes for healthcare stakeholders. The company's clients include hospitals, clinics, and orthopaedic surgeons who are looking to enhance the precision and effectiveness of their treatments. OrthoSensor's business model revolves around the development and sale of these advanced sensor technologies, which generate revenue through direct sales to healthcare providers and institutions. The company aims to lead the digital evolution of musculoskeletal care by transforming it from a qualitative art to a quantified science. This approach not only benefits patients by providing more accurate and effective treatments but also offers economic advantages to healthcare providers by potentially reducing costs and improving efficiency.
Keywords: orthopaedics, sensor technology, musculoskeletal care, evidence-based treatments, healthcare providers, clinical outcomes, economic outcomes, digital evolution, precision medicine, orthopaedic surgeons.